Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

Mon, 12th Feb 2024 09:41

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

Stifel cuts AstraZeneca price target to 12,000 (12,550) pence - 'buy'

----------

Barclays cuts AstraZeneca price target to 12,500 (13,500) pence - 'overweight'

----------

UBS cuts AstraZeneca price target to 9,900 (10,700) pence - 'sell'

----------

Deutsche Bank cuts Legal & General price target to 300 (305) pence - 'buy'

----------

RBC cuts JD Sports price target to 135 (150) pence - 'outperform'

----------

Barclays raises Diploma price target to 3,800 (3,400) pence - 'overweight'

----------

Goldman Sachs raises BAT price target to 2,750 (2,700) pence - 'neutral'

----------

JPMorgan cuts BAT price target to 2,550 (2,700) pence - 'neutral'

----------

Berenberg raises Compass price target to 2,460 (2,430) pence - 'buy'

----------

DZ Bank cuts fair value for Anglo American to 1,550 (1,600) pence - sell

----------

JPMorgan cuts Anglo American price target to 2,350 (2,450) pence - 'overweight'

----------

FTSE 250

----------

JPMorgan cuts Ashmore price target to 184 (185) pence - 'underweight'

----------

SMALL CAP AND OTHER MAIN MARKET

----------

Deutsche Bank raises Just Eat Takeaway price target to 23 (22) EUR - 'buy'

----------

Deutsche Bank starts Deliveroo with 'buy' - price target 180 pence

----------

Jefferies raises Greencore price target to 100 (90) pence - 'hold'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
Today 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Today 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

Today 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe a...

Today 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', ...

26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.